The endogenous secretion of growth hormone (GH) is sexually dimorphic in rats with females having a more even and males a more pulsatile secretion and low trough levels. The mode of GH administration, mimicking the sexually dimorphic secretion, has different systemic effects. In the brains of male rats, we have previously found that the mode of GH administration differently affects neuron-haemoglobin beta (Hbb) expression whereas effects on other transcripts were moderate. The different modes of GH administration could have different effects on brain transcripts in female rats. Hypophysectomised female rats were given GH either as injections twice daily or as continuous infusion and GH-responsive transcripts were assessed by quantitative reverse transcription polymerase chain reaction in the hippocampus and parietal cortex (cortex). The different modes of GH-administration markedly increased Hbb and 5′-aminolevulinate synthase 2 (Alas2) in both brain regions. As other effects were relatively moderate, a mixed model analysis (MMA) was used to investigate general effects of the treatments. In the hippocampus, MMA showed that GH-infusion suppressed glia-and neuron-related transcript expression levels, whereas GH-injections increased expression levels. In the cortex, GH-infusion instead increased neuronrelated transcripts, whereas GH-injections had no significant effect. Interestingly, this contrasts to previous results obtained from male rat cortex where GH-infusion generally decreased expression levels. In conclusion, the results indicate that there is a small but significant difference in response to mode of GH administration in the hippocampus as compared to the cortex. For both modes of GH administration, there was a robust effect on Hbb and Alas2.
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rats (Schneider-Rivas et al. 1995 , Le Greves et al. 2006 as well as expression of plasticity-related transcripts (Aberg et al. 2010) .
When GH is secreted from the pituitary or administered peripherally, it stimulates the liver to release insulin-like growth factor-I (IGF-I) (Mathews et al. 1986) , which mediates some of the effects of GH. In the brain, both GH and IGF1 have been shown to cross the bloodbrain barrier (Armstrong et al. 2000 , Pan et al. 2005 , Nishijima et al. 2010 .
GH receptors are expressed in both glial and neuronal cells, and it is suggested that GH can stimulate both cell types directly (Lobie et al. 1993 , Hallberg & Nyberg 2012 . Many of the effects of GH are related to different aspects of brain plasticity. For instance, GH treatment shows increase in cell genesis and in number of newborn neurons in the adult brain (Aberg et al. 2009 (Aberg et al. , 2010 . Likewise, IGF-I (D' Ercole et al. 1996 , Folli et al. 1996 and IGF-I receptors are expressed in the brain by neurons, glial and endothelial cells (Yan et al. 2011) . Furthermore, GH and IGF-I protect the brain against hypoxic-ischaemic injuries (HI) (Gustafson et al. 1999 , Pathipati et al. 2009 ).
In humans and in rats, GH is secreted from the pituitary in a circadian rhythm that differs between the sexes. In rats, the mechanism of this sex discrepancy has been more studied than in humans. In male rats, maintaining low basal GH levels has been shown to be dependent on neonatal priming by androgens of the hypothalamus as well as by continuous adult presence of testosterone (Jansson & Frohman 1987) . In female rats, oestrogen elevates basal plasma GH levels and suppresses GH pulses (Jansson et al. 1985) . Also in humans, it is believed that the sexual dimorphic GH secretion results from a response to the inhibitory effects of 17β-oestradiol and the stimulatory effect of testosterone acting on hypothalamic somatostatin release (Devesa et al. 1991) . This gives rise to low trough levels and high GH peaks with 3-to 4-h intervals in male rodents, whereas more frequent peaks and almost no troughs are observed in female rodents, thereby a more even GH secretory pattern (Eden 1979 , MacLeod et al. 1991 . In rats, the pulsatile mode of GH treatment, which imitates the male endogenous GH secretion (Jansson et al. 1982) , enhanced Igf1 mRNA levels more than infusions both in rib growth plate and in skeletal muscle (Isgaard et al. 1988) . So far, the effects of different modes of GH administration have only been investigated in the hippocampus and in the parietal cortex of male hypophysectomised rats (Walser et al. 2014) . Specifically, we found that the two brain regions are diversely regulated by different modes of GH administration to a moderate extent with the exception for the highly regulated neuronal-haemoglobin beta (Hbb).
However, it is not known whether the mode of GH treatment affects the female rat brain. By analogy with the different effects seen in the periphery, our hypothesis was that different modes of GH administrations, mimicking the specific secretion patterns in males and females, might give rise to responses different from those of male rat brains. Therefore, we administered GH as two daily Table 1 Abbreviations of probes and gene names, and the names of the transcripts that are used in the present study. injections or as infusions by osmotic minipumps, and investigated the effects on previously known transcripts related to plasticity and transcripts related to oxygenation in the hippocampus and parietal cortex (henceforth cortex). The transcripts were divided into four categories (Walser et al. 2014) : GH-, neuron-, glia-related and neuronHbb (Table 1 and Supplementary Table 1 for further details, see section on supplementary data given at the end of this article). Three transcripts, which have not been studied before, were also measured as they are functionally associated with Hbb and oxygenation (Walser et al. 2014) . These were the rate-limiting enzymes of the haeme synthesis delta-aminolevulinate synthase 1 and 2 (Alas1, Alas2) and the hypoxia-inducible factor 1-alpha (HIF1a), which functions as a master transcriptional regulator of the adaptive response to hypoxia ( 
Materials and methods

Animals and hormonal treatment
The experiments were performed in female (n = 21) Sprague-Dawley rats (Møllegaard Breeding Center Ltd, Ejby, Denmark), as previously described ( (Walser et al. 2011) and Supplementary information). Normal pituitaryintact rats (henceforth intact) and hypophysectomised rats (henceforth Hx) were kept to monitor effects of Hx per se, and to evaluate whether bovine-GH (bGH) restored specific transcript expression to relevant physiological levels. The effects of hormonal administration were assessed in rats, which were Hx at 60 days of age (n = 5-6 in each group). Hormone administration was maintained for 7 days and initiated 10 days after Hx, to sort out rats with incomplete Hx as determined by weight gain. All Hx rats received substitution therapy with cortisol phosphate (C; 400 µg/kg/day; Solucortef, Upjohn, Puurs, Belgium) and l-thyroxine (T 4 ; 10 µg/kg/day; Nycomed, Oslo, Norway), which were diluted in saline and administered subcutaneously once daily at 08:00 h (Jansson et al. 1982) . These rats were randomised into a control group (Hx) and two bovine GH (bGH)-groups. Bovine GH (recombinant), donated by American Cyanamide Co (Princeton, NJ, USA), was prepared as described before and given as a subcutaneous continuous infusion (0.7 mg/kg per day) for 7 days using mini-osmotic pumps (Alzet 2004 model) implanted subcutaneously in the neck (henceforth GHi) or as subcutaneous injections (henceforth GHx2; i.e. 0.35 mg/kg, twice daily, equalling a total of 0.7 mg/kg per 24 h) (Oscarsson et al. 1999) . Tissues were immediately dissected and frozen in liquid nitrogen and stored at −80˚C. All treatment procedures were approved by the Board of Animal Ethics of the University of Gothenburg. Of note is that samples from the intact, Hx and GHi groups have been used in previous experiments (Walser et al. 2011) but the transcripts assessed then (Hbb, Gabbr1) have here been re-analysed with quantitative reverse transcription polymerase chain reaction (Q-RT-PCR) using new primers.
Quantitative reverse transcription polymerase chain reaction (Q-RT-PCR)
To quantify the different transcripts, we used the Q-RT-PCR. Total RNA was extracted from hippocampus and cortex using the Tri Reagent solution (Ambion) and quantified by spectrophotometric analysis of absorption at 260 vs 280 nm using a Nanodrop 1000 (Thermo Scientific). cDNA was prepared from 250 ng total RNA, (High-Capacity cDNA Reverse Transcription Kit, Applied Biosystems). Q-RT-PCR analysis was performed using an ABI Prism 7900 Sequence Detection System (Applied Biosystems). Predesigned, TaqMan Gene Expression Assays were used (Applied Biosystems) ( Table 1 , for further details see http://www.appliedbiosystems.com).
Detailed information and references on the transcripts are found in Table 2 . For information on the calculations of the Q-RT-PCR, Supplementary information (Walser et al. 2014) .
Statistical analysis
Values are presented as the mean ± 95% confidence interval (CI). Comparisons between any two groups were made using unpaired t-tests (Table 4) . As the primary objective was to compare GHi and GHx2, these analyses were not corrected for multiple comparisons. Furthermore, as the transcripts were selected for previous GH-responsiveness, other secondary comparisons are shown for convenience but are not corrected for multiple comparisons. Correlations were calculated according to the Pearson correlation coefficient expressed as r.
A mixed model analysis (MMA) was used for all other statistical comparisons, such as to evaluate effects of GHi and GHx2 related to each of the categories of transcripts. For further information on the MMA, Supplementary 233:2 information (Walser et al. 2014) . P < 0.05 were considered statistically significant.
Results
GH exerts systemic effects
Hx rats received bGH either as subcutaneous infusion (GHi) or injections twice daily (GHx2) for 7 days. bGH normalised weight gains in Hx rats to slightly above the weight gain observed in intact rats (P < 0.001) ( Table 3 ), indicating that the administered GH had the expected systemic effect on body growth. Of note is that GHx2 increased weight gain significantly more (+20%) than GHi.
GH administration produces a robust response in Hbb and Alas2 expression but has a moderate influence on other transcripts in both the hippocampus and cortex
The selection of transcripts investigated in this study is based on results from previous studies showing that they are regulated by GH treatment in the adult male rat brain, and divided into GH-, neuron-or glia-related transcripts (Tables 1, 2 and Supplementary Table 1) .
Overall, both GHi and GHx2 induced small and in most cases non-significant changes in transcript abundance, except for the robust increases in Hbb and Alas2 (Table 4) . In most cases, there was some agreement with previous reports but not necessarily in both brain regions or for both modes of administration. Hx per se only significantly affected a few transcripts, namely Alas2 (P = 0.001) in the hippocampus and Hbb (P = 0.005), Esr1 (P = 0.023), Gria1 (P = 0.029) and Alas2 (P = 0.042) in the cortex.
When testing our primary hypothesis, whether there was different magnitude in response to GHi or GHx2, only a few specific transcripts exhibited statistically significant differences Gfap, Igf1r, Psd95 and Alas1 in the hippocampus, and Hbb, Psd95 and Hif1α in the cortex (Table 4) . It is of note that in all these cases, GHx2 showed a higher response than GHi in the hippocampus, whereas the opposite, except for Hbb, was the case in the cortex. 
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General effects in the hippocampus
To further study the general effect of mode of administration and category of transcript, a MMA statistical analysis was used. For the specific categories of transcripts, the MMA revealed a significant difference in the neuron-and glia-related group between GHi and GHx2 groups, with a higher expression for GHx2 (Fig. 1A) . In the neuron-Hbb category, there were significant differences between both Hx vs GHi and Hx vs GHx2 (Fig. 1A) . Furthermore, the MMA did not reveal any significant differences in the GH-related transcripts (Fig. 1A) .
General effects in the cortex
Specifically, there was a significant difference between GHi and GHx2 (Fig. 1B) in the neuron-related category, with negative effects of GHx2 as compared to the positive effects of GHi. This finding was in contrast to the results found in hippocampal expression where the effect of GHx2 was in general larger than the effect of GHi. In the neuronHbb category, there were significant differences between Hx and both of GHi and GHx2 and between GHi vs GHx2 (Fig. 1B) , with a higher expression for GHx2, consistent with the results in the hippocampus. The GH-related and glia-related transcripts were not significantly affected by the mode of GH-administration (NS, Fig. 1B ).
Possible functional associations indicated by correlation patterns
Statistical correlation can be used to indicate which transcripts have a functional association. Thus, a statistical association between a transcript and weight increase may indicate one type of effect of GH, possibly by peripheral or direct effects of GH. In contrast, the other associations to components of the GH-IGF1 system may indicate a regulation by local components. Accordingly, it is of note that the expression of Hbb and Alas2 was highly associated with weight gain in both brain regions (Table 5) , whereas they were neutral or negatively associated with Igf1r. For all other transcripts, there was a neutral or negative association with weight gain, except for Gja1 in the hippocampus (showed a positive association with weight gain). Further, these transcripts all showed a robust positive association with Igf1r. This was most evident in the hippocampus.
Discussion
This study aimed to investigate responses to different modes of GH administration to hypophysectomised female rats with respect to previously known GH-induced plasticity-related transcripts in the hippocampus and the cortex. The study shows that GH affects the selected transcripts differently in the hippocampus compared with the cortex albeit to a moderate degree. One exception was the neuron-Hbb category, where GHi and to larger degree GHx2 increased expression by 2-3 fold in both brain regions ( Fig. 1 and Table 4 ). For the other transcripts, primary statistical analysis for each of the transcripts revealed only a few instances of significant differences between GHi and GHx2 (Table 4) . Still, the MMA confirmed that the relatively moderate responses are mostly in the same direction with respect to Hx and intact rats across the transcripts. With regard to category of transcript, MMA revealed many cases of significant differences between GHi and GHx2. Importantly, GHi and GHx2 acted differently in the hippocampus and in the cortex. Correlation analysis between weight gain, GH-related transcripts which are local components of the GH-IGF1 system, and the specific transcripts revealed two types of associations. Overall, Hbb and Alas2 were associated with weight gain whereas most other transcripts were associated with the local Igf1r expression. These findings are discussed below.
Differences between GHi and GHx2
There were moderate but conceptual differences in the response to the two different administration paradigms. Peripherally, this was reflected in an expected higher weight gain of GHx2 as compared to GHi (Table 3 ). The responses in the hippocampus and in the cortex are sequentially discussed below.
The hippocampus showed a significant difference in response between GHi and GHx2. Specifically, GHi suppressed glia-and neuron-related transcript abundance, whereas GHx2 restored abundance to intact levels (Fig. 1A) . Thus, GHx2 administration could be more optimal in eliciting a response in the hippocampus regarding neuron-and glia-related transcripts, which is in agreements with reports on systemic responses to different modes of GH administration. For example, an administration frequency of 2-4 injections per day of GH optimises body growth in male Hx rats (Jansson et al. 1982) . In agreement, the study by Isgaard (Isgaard et al. 1988 ) demonstrated that pulsatile treatment induces local Igf1 in skeletal muscle and rib growth plate more effectively than continuous GH in male Hx rats. Our results would thus indicate that GHx2 is more effective to elicit responses not only in the male, but also in the female hippocampus.
In contrast, in the cortex, GHi increased neuronrelated transcripts, whereas GHx2 had no effect (Fig. 1B) . The glia-and GH-related categories were unaffected by administration of either GHi or GHx2 (Fig. 1) . This discrepancy between the pattern of response to GHi and GHx2 in the hippocampus and in the cortex could partly be explained by generally tighter associations between the Igf1r and the other transcripts in the cortex as compared to the hippocampus (Table 5) . The two-tailed correlation matrix was calculated according to Pearson (see 'Materials and methods' section). The correlation coefficients (r) represent analysis of all animals (n = 21), with significance levels (P). Significant correlations are shown in bold. Category of transcript is abbreviated 'Cat.', and the specific abbreviations of each category of transcript (N, N-Hbb, N and G) is found in Tables 1 and 2 . N/A, not applicable. *P < 0.05, **P < 0.01.
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Effects of GH administration with respect to neuron-Hbb neuroprotection and oxygenation-promoting properties
We have previously demonstrated that GH administration in female (Walser et al. 2011) and male (Walser et al. 2014 ) hypophysectomised rats robustly regulates the level of the Hbb transcript in the brain. In the present experiments, we also show that the transcript for the rate-controlling enzyme of haeme biosynthesis Alas2 is similarly affected by GH. This gives support to that GH may be linked to neuroprotection against hypoxia. There may be several explanations to this finding. To begin with, Hx may lower the basal metabolic rate and subsequent administration of GH may restore the basal metabolism accompanied by an increased oxygen consumption (Goodman & Grichting 1983) . Indeed, an upregulation of brain Hbb has been shown after ischaemia-induced hypoxia (He et al. 2009 ). Furthermore, as the neuron-Hbb category responds to Hx by a considerable decrease in the levels of transcripts, in both sexes and in both brain regions, we conclude that this is likely driven by a mechanism unrelated to the effect on the other transcripts, whose generally tighter correlations to the Igf1r, instead suggests that the effects of GH may be more closely mediated to IGF-I signalling via the Igf1r (Table 5) .
Taken together, it appears that endogenous neuronal (non-erythrocyte) haemoglobin in neurons is involved in neuroprotection although its function is still not fully clear.
Differences between the sexes Interestingly, when comparing the results from our previous investigations in male rats (Walser et al. 2014) with the results in the present study of female rats, there is a marked difference in response between the sexes. In both sexes, in the hippocampus, the transcripts were generally increased by GHx2 whereas this effect was small or absent after GHi. However, in the cortex, these transcripts were unresponsive to GHx2 but responded in opposite directions to GHi; in females with an increase and in males with a decrease (Fig. 1A and B) (Walser et al. 2014) . This indicates that the two brain regions are divergently receptive to the two different administration strategies. Other reasons put forward for sex differences in expression are that oestradiol treatment increases local GH expression in the cerebellum and in the hippocampus with only a marginal effect in the hypothalamus, and that the sex chromosome regulates GH expression within the hypothalamus (Quinnies et al. 2015) . Indeed, this suggests that the two brain regions, the hippocampus and the cortex may be differentially affected by the two administration paradigms of GH in the sexes. Future studies on GH administration should preferably also include a group of sex-hormone substituted rats, in addition to the cortisol and thyroxine-substituted Hx rats.
Clinical relevance
By administration of GH in two different modes, followed by attaining the expression of sixteen transcripts we tried to provide a more comprehensive picture of the effects of GH in the hippocampus and in the cortex. Although, the mode of administration did not have a decisive importance in our female rats, GHx2 in spite of being more male-like than GHi, elicited a somewhat greater effect on all transcripts in the hippocampus and in particular on Hbb and Alas2.
Neuronal-Hbb may have neuroprotective properties, as discussed above for hypoxic neuroprotection (He et al. 2009 ), but, in addition, there are also indications that Hbb is involved in multiple sclerosis (Brown et al. 2016) and in Parkinson's disease (Shephard et al. 2014) . Furthermore, a link between Hbb/Alas2 and dopamine signalling malfunction in the restless legs syndrome has been shown (Jellen et al. 2013) . The fact that GHx2 decreased expression of most transcripts except Hbb and Alas2 in the cortex, suggests that GHi may be favourable to induce these plasticity-related transcripts in this brain region. However, such a conclusion would need confirmation in a study that also includes substitution of sex hormones.
Neuroprotective effects are most often considered to involve the acute phase of an injury, while the ensuing recovery phase involves more of effects on long-acting plasticity. Although the significant differences between modes of GH administration in the neuron-and gliacategories of transcripts were small, they may nevertheless be important for long-term plasticity after brain injuries. Specifically, chronic central treatment of a unilateral stroke with GH in adult rats was associated with slightly more rapid recovery of motor functions and with better spatial memory (Pathipati et al. 2009 ). Moreover, the consequences of TBI can be improved in humans by an acute/subacute and delayed administration of GH several years after the TBI (Maric et al. 2010) . Therefore, GH administration paradigms may have significance for both acute neuroprotection and long-term plasticity and thereby the outcomes of brain injuries.
